Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023100 · ClinicalTrials.gov registry record · Phase 1
A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01023100 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 5 participants.
The verdict
NCT01023100, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.
Interventions
- DRUG CP 690,550 oral solutions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023100
The ClinicalTrials.gov registry entry for NCT01023100 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CP 690,550 oral solutions is the first listed.
NCT01023100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023100 about?
NCT01023100 is a clinical study titled "A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers". This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.
What is the current status of trial NCT01023100?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2010-03. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01023100?
The interventions under investigation include: CP 690,550 oral solutions (DRUG).
Who is sponsoring clinical trial NCT01023100?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.